ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.
- Creator: Lozinski, Mathew , Bowden, Nikola A. , Graves, Moira C. , Fay, Michael , Day, Bryan W. , Stringer, Brett W. , Tooney, Paul A.
- Resource Type: journal article
- Date: 2024
Transcriptomic Profiling of DNA Damage Response in Patient-Derived Glioblastoma Cells before and after Radiation and Temozolomide Treatment
- Creator: Lozinski, Mathew , Bowden, Nikola A. , Graves, Moira C. , Fay, Michael , Day, Bryan W. , Stringer, Brett W. , Tooney, Paul A.
- Resource Type: journal article
- Date: 2022
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients
- Creator: Climans, Seth A. , Brandes, Alba A. , Phillips, Claire , Roa, Wilson , Wick, Wolfgang , Winch, Chad , Mason, Warren P. , Cairncross, J. Gregory , Ding, Keyue , Fay, Michael , Laperriere, Normand , Menten, Johan , Nishikawa, Ryo , O'Callaghan, Christopher J. , Perry, James R.
- Resource Type: journal article
- Date: 2020
Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial
- Creator: Khasraw, Mustafa , Lee, Adrian , McCowatt, Sally , Kerestes, Zoltan , Buyse, Marc E. , Back, Michael , Kichenadasse, Ganessan , Ackland, Stephen , Wheeler, Helen
- Resource Type: journal article
- Date: 2016
O⁶-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib
- Creator: Watson, A. J. , Middleton, M. R. , Haydon, A. , Kefford, R. , Lorigan, P. , Mortimer, P. , Sabharwal, A. , Hayward, O. , Margison, G. P. , McGown, G. , Thorncroft, M. , Ranson, M. , Hersey, P. , McArthur, G. , Davis, I. D. , Thomson, D. , Beith, J.
- Resource Type: journal article
- Date: 2009
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with Carboplatin and Paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma
- Creator: Hauschild, Axel , Agarwala, Sanjiv S , Peschel, Christian , Schadendorf, Dirk , Garbe, Claus , O'Day, Steven , Daud, Adil , White, J. Michael , Xia, Chenghua , Patel, Kiran , Kirkwood, John M. , Keilholz, Ulrich , Trefzer, Uwe , Hogg, David , Robert, Caroline , Hersey, Peter , Eggermont, Alexander , Grabbe, Stephan , Gonzalez, Rene , Gille, Jens
- Resource Type: journal article
- Date: 2009